Drugs / GFD
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01292070 | Mar → Apr 2011 | — | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GFD | “Intradermal Human Fcγ1-Fel d1 fusion protein (GFD)” NCT01292070 ↗ |
| Modality | Protein / enzyme biologic | “a new protein developed to treat sensitivity to cat allergens” NCT01292070 ↗ |